Time period given by analyst is one year when Max Healthcare Institute Ltd. price can reach defined target.
Max Healthcare Institute Ltd., incorporated in the year 2001, is a Large Cap company (having a market cap of Rs 34629.13 Crore) operating in Hospitals & Allied Services sector.
Max Healthcare Institute Ltd. key Products/Revenue Segments include HealthCare Services, Drugs & Pharmaceuticals, Interest and Other Operating Revenue for the year ending 31-Mar-2020.
Financials
For the quarter ended 30-06-2021, the company reported a Consolidated Total Income of Rs 1026.13 Crore, up 23.55 % from last quarter Total Income of Rs 830.54 Crore and up 272.35 % from last year same quarter Total Income of Rs 275.58 Crore. Company reported net profit after tax of Rs 146.92 Crore in latest quarter.
Investment Rationale
The brokerage revises estimates to reflect new bed expansion plans and forecast 17%/24% revenue/EBITDA CAGR over FY21-28e. Based on the long term projections, the brokerage sees ~95% upside potential over the next five years. The brokerage revises TP to INR410/share, based on Mar’24 EBITDA (from Mar’23).
Promoter/FII Holdings
Promoters held 70.46 per cent stake in the company as of June 30, 2021, while FIIs held 14.05 per cent, DIIs 7.95 per cent and public and other 7.54 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
